bioAffinity Technologies, Inc. - PE Ratio

The PE Ratio as of June 2026 (TTM) for bioAffinity Technologies, Inc. (BIAF) is -0.18

According to bioAffinity Technologies, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.18. This represents a change of -62.60% compared to the average of -0.48 of the last 4 quarters.

bioAffinity Technologies, Inc. (BIAF) Historical PE Ratio (quarterly & annually)

How has BIAF PE Ratio performed in the past?

The mean historical PE Ratio of bioAffinity Technologies, Inc. over the last ten years is -4.88. The current -0.18 PE Ratio has changed 268.52% with respect to the historical average. Over the past ten years (40 quarters), BIAF's PE Ratio was at its highest in in the June 2021 quarter at 3.84. The PE Ratio was at its lowest in in the June 2022 quarter at -64.24.

bioAffinity Technologies, Inc. (BIAF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of bioAffinity Technologies, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

bioAffinity Technologies, Inc. (BIAF) Average PE Ratio

How has BIAF PE Ratio performed in the past?

The current PE Ratio of bioAffinity Technologies, Inc. (BIAF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

bioAffinity Technologies, Inc. (BIAF) PE Ratio vs. Peers

How is BIAF’s PE Ratio compared to its peers?

bioAffinity Technologies, Inc.’s PE Ratio is less than Artelo Biosciences, Inc. (-0.07), less than GT Biopharma, Inc. (-0.08), less than Mobile-health Network Solutions Class A Ordinary Shares (-0.09), less than WORK Medical Technology Group Ltd. (-0.03), less than Carisma Therapeutics, Inc. (0.10), less than Psyence Biomedical Ltd. (1.77), less than Revelation Biosciences, Inc. (-0.07), less than Protagenic Therapeutics, Inc. (-0.12), less than Lipella Pharmaceuticals Inc. (-0.03), greater than Salarius Pharmaceuticals, Inc. (-0.19),

Build a custom stock screener for bioAffinity Technologies, Inc. (BIAF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like bioAffinity Technologies, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

bioAffinity Technologies, Inc. (BIAF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like bioAffinity Technologies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.